Oncocyte Corporation announced that Ronnie Andrews will step down from his role as a director of the company's board of directors, effective December 1, 2022. In order to ensure a smooth transition effective as of December 2, 2022, and Mr. Andrews will continue to act a consultant until February 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | +0.36% | +3.77% | +10.00% |
03/06 | Oncocyte Corporation Announces Promising Results in A Phase 2 Clinical Trial | CI |
30/05 | Oncocyte Corporation Announces Favorable Oncocyte Vitgraft Kidney Study Results | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.00% | 36.62M | |
+17.71% | 3.73B | |
+4.92% | 2.41B | |
-19.94% | 2.01B | |
-19.77% | 1.63B | |
+20.31% | 1.08B | |
+27.42% | 776M | |
-9.83% | 679M | |
-29.39% | 508M | |
-6.96% | 291M |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Corporation Announces Step Down of Ronnie Andrews as Board of Directors, Effective December 1, 2022